HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunotherapy shows promise in Phase III neuroblastoma trial.

Authors
JournalNature reviews. Drug discovery (Nat Rev Drug Discov) Vol. 8 Issue 8 Pg. 604 (Aug 2009) ISSN: 1474-1784 [Electronic] England
PMID19644467 (Publication Type: News)
Chemical References
  • Antibodies, Monoclonal
  • Gangliosides
  • ganglioside, GD2
Topics
  • Antibodies, Monoclonal (adverse effects, pharmacology)
  • Clinical Trials, Phase III as Topic
  • Gangliosides (immunology)
  • Humans
  • Immunotherapy (adverse effects, methods)
  • Neuroblastoma (immunology, mortality, therapy)
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: